Overview

A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Status:
Enrolling by invitation

Trial end date:
2023-06-20

Target enrollment:

Participant gender:

Summary

This is a Phase 3, open-label study to evaluate the safety of BOTOX Injection in Adult Participants with Platysma Prominence

Phase:

Phase 3

Details

Lead Sponsor:

Allergan